What Happened?
Cambridge, -based Merus Promoted Peter Silverman as Executive Vice President and General Counsel
About the Company
Merus is developing best-in-class therapeutics to treat and potentially cure cancer patients. Our most advanced development programs use the Biclonics® format. Biclonics® are capable of simultaneously attacking tumors in multiple ways. For example by activating the immune system to kill tumor cells and directly inhibiting tumor cell growth and survival pathways.
About the Person
Peter Silverman is Executive Vice President and General Counsel at Merus. Previously, Peter held various senior legal leadership roles in the industry.
Info Source
News
Short Profile